These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Pirenzepine and carbenozolone in gastric ulcer. Preliminary results of a multicentre double-blind controlled clinical trial.
    Author: Barbara L, Belsasso E, Blasi A, Caenazzo E, Di Febo G, Di Mario F, Giorgi-Conciato M, Marletta F, Miglioli M, Petrillo M, Salvagnini M, Scalabrin G.
    Journal: Scand J Gastroenterol Suppl; 1979; 57():21-4. PubMed ID: 396653.
    Abstract:
    Pirenzepine (PRZ) 75 mg/day for 1 week followed by 50 mg/day for 3 weeks did not show a good activity in gastric ulcer healing in comparison to carbenoxolone (CB) (300 mg/day for 1 week followed by 200 mg/day for 3 weeks). The tolerability of PRZ seemed to be better than that of CB. The increase in the daily dose of PRZ to 100 mg/day for 4 weeks led to better results in the patients who have completed satisfactorily the treatment up to now. PRZ's tolerability was greater than CB's. The results of this study are preliminary to further trial.
    [Abstract] [Full Text] [Related] [New Search]